South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study

Abstract Background This study is part of a multicountry matched-cohort study designed to estimate the risk of long-term neurodevelopmental impairment (NDI) of children exposed to invasive group B Streptococcus (iGBS). The specific objective of this paper is to compare NDI across domains of iGBS sur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2022-01, Vol.74 (Supplement_1), p.S24-S34
Hauptverfasser: John, Hima B, Arumugam, Asha, Priya, Mohana, Murugesan, Nandhini, Rajendraprasad, Nandhini, Rebekah, Grace, Paul, Proma, Chandna, Jaya, Lawn, Joy E, Santhanam, Sridhar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S34
container_issue Supplement_1
container_start_page S24
container_title Clinical infectious diseases
container_volume 74
creator John, Hima B
Arumugam, Asha
Priya, Mohana
Murugesan, Nandhini
Rajendraprasad, Nandhini
Rebekah, Grace
Paul, Proma
Chandna, Jaya
Lawn, Joy E
Santhanam, Sridhar
description Abstract Background This study is part of a multicountry matched-cohort study designed to estimate the risk of long-term neurodevelopmental impairment (NDI) of children exposed to invasive group B Streptococcus (iGBS). The specific objective of this paper is to compare NDI across domains of iGBS survivors with a matched non iGBS group in our population. Methods Survivors of iGBS in a South Indian hospital were identified and recruited between January 2020 and April 2021. Cases were compared with age- and gender-matched non iGBS children. Participants were assessed using Bayley Scales of Infant and Toddler Development–3rd edition (BSID-III), Wechsler Preschool and Primary Scale of Intelligence–4th edition (WPPSI-IV), Wechsler Intelligence Scale for Children–5th edition (WISC-V), Child Behavior Checklist (CBCL), and Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), depending on age. Results Our cohort comprised 35 GBS-exposed and 65 matched non iGBS children, aged 1–14 years. The iGBS-exposed group had 17 (48.6%) children with impairment in ≥1 domain compared to 25 (38%) in the non iGBS group (unadjusted OR, 1.51; 95% CI, .65–3.46), 9 (26%) children with “multi-domain impairment” compared to 10 (15.4%) in the non iGBS group (unadjusted OR, 1.90; 95% CI, .69–5.24), and 1 (2.9%) child with moderate to severe impairment compared to 3 (4.6%) in the non iGBS group (unadjusted OR, .60; 95% CI, .06–6.07). In the iGBS group, more children had motor impairments compared with the non iGBS group (unadjusted OR, 10.7; 95% CI, 1.19–95.69; P = .034). Conclusions Children with iGBS seem at higher risk of developing motor impairments compared with a non iGBS group.
doi_str_mv 10.1093/cid/ciab792
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8775645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cid/ciab792</oup_id><sourcerecordid>2576658113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-4695fcab7bfc8458d921436d3b3b1cb943fc8a4756f6c6de74c80b21005f79043</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EoqWwYo-8QkgoYMeXOCyQhimUSoUuCmvLsU9IUBIHX0ZqV7wGr8eTYDRDBRsWli3783d8_CP0mJIXlLTspR1dGaZr2voOOqaCNZUULb1b1kSoiiumjtCDGL8SQqki4j46YlwIJYk4RjdXPqcBny9uNAveDuPkAiw_v_-I-CPk4B3sYPLrDEsyE77MyfoZIt70CQI-Cz6v-A2-SgHW5K23Nsfi2pk47gCfjhFMhFd4gz-YZAdw1dYPPqRyIbvrh-heb6YIjw7zCfr87u2n7fvq4vLsfLu5qCyndaq4bEVvS3tdbxUXyrU15Uw61rGO2q7lrOwb3gjZSysdNNwq0tWUENE3LeHsBL3ee9fczeBsaSWYSa9hnE241t6M-t-TZRz0F7_TqilSLorg2UEQ_LcMMel5jBamySzgc9S1aKQUilJW0Od71AYfY4D-tgwl-ndauqSlD2kV-snfL7tl_8RTgKd7oPzzf02_ACCYoek</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576658113</pqid></control><display><type>article</type><title>South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study</title><source>MEDLINE</source><source>Oxford Journals A-Z Collection</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>John, Hima B ; Arumugam, Asha ; Priya, Mohana ; Murugesan, Nandhini ; Rajendraprasad, Nandhini ; Rebekah, Grace ; Paul, Proma ; Chandna, Jaya ; Lawn, Joy E ; Santhanam, Sridhar</creator><creatorcontrib>John, Hima B ; Arumugam, Asha ; Priya, Mohana ; Murugesan, Nandhini ; Rajendraprasad, Nandhini ; Rebekah, Grace ; Paul, Proma ; Chandna, Jaya ; Lawn, Joy E ; Santhanam, Sridhar</creatorcontrib><description>Abstract Background This study is part of a multicountry matched-cohort study designed to estimate the risk of long-term neurodevelopmental impairment (NDI) of children exposed to invasive group B Streptococcus (iGBS). The specific objective of this paper is to compare NDI across domains of iGBS survivors with a matched non iGBS group in our population. Methods Survivors of iGBS in a South Indian hospital were identified and recruited between January 2020 and April 2021. Cases were compared with age- and gender-matched non iGBS children. Participants were assessed using Bayley Scales of Infant and Toddler Development–3rd edition (BSID-III), Wechsler Preschool and Primary Scale of Intelligence–4th edition (WPPSI-IV), Wechsler Intelligence Scale for Children–5th edition (WISC-V), Child Behavior Checklist (CBCL), and Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), depending on age. Results Our cohort comprised 35 GBS-exposed and 65 matched non iGBS children, aged 1–14 years. The iGBS-exposed group had 17 (48.6%) children with impairment in ≥1 domain compared to 25 (38%) in the non iGBS group (unadjusted OR, 1.51; 95% CI, .65–3.46), 9 (26%) children with “multi-domain impairment” compared to 10 (15.4%) in the non iGBS group (unadjusted OR, 1.90; 95% CI, .69–5.24), and 1 (2.9%) child with moderate to severe impairment compared to 3 (4.6%) in the non iGBS group (unadjusted OR, .60; 95% CI, .06–6.07). In the iGBS group, more children had motor impairments compared with the non iGBS group (unadjusted OR, 10.7; 95% CI, 1.19–95.69; P = .034). Conclusions Children with iGBS seem at higher risk of developing motor impairments compared with a non iGBS group.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciab792</identifier><identifier>PMID: 34558605</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adolescent ; Child ; Child Development ; Child, Preschool ; Cohort Studies ; Humans ; Infant ; Streptococcus agalactiae ; Supplement</subject><ispartof>Clinical infectious diseases, 2022-01, Vol.74 (Supplement_1), p.S24-S34</ispartof><rights>The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-4695fcab7bfc8458d921436d3b3b1cb943fc8a4756f6c6de74c80b21005f79043</citedby><cites>FETCH-LOGICAL-c412t-4695fcab7bfc8458d921436d3b3b1cb943fc8a4756f6c6de74c80b21005f79043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34558605$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>John, Hima B</creatorcontrib><creatorcontrib>Arumugam, Asha</creatorcontrib><creatorcontrib>Priya, Mohana</creatorcontrib><creatorcontrib>Murugesan, Nandhini</creatorcontrib><creatorcontrib>Rajendraprasad, Nandhini</creatorcontrib><creatorcontrib>Rebekah, Grace</creatorcontrib><creatorcontrib>Paul, Proma</creatorcontrib><creatorcontrib>Chandna, Jaya</creatorcontrib><creatorcontrib>Lawn, Joy E</creatorcontrib><creatorcontrib>Santhanam, Sridhar</creatorcontrib><title>South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Abstract Background This study is part of a multicountry matched-cohort study designed to estimate the risk of long-term neurodevelopmental impairment (NDI) of children exposed to invasive group B Streptococcus (iGBS). The specific objective of this paper is to compare NDI across domains of iGBS survivors with a matched non iGBS group in our population. Methods Survivors of iGBS in a South Indian hospital were identified and recruited between January 2020 and April 2021. Cases were compared with age- and gender-matched non iGBS children. Participants were assessed using Bayley Scales of Infant and Toddler Development–3rd edition (BSID-III), Wechsler Preschool and Primary Scale of Intelligence–4th edition (WPPSI-IV), Wechsler Intelligence Scale for Children–5th edition (WISC-V), Child Behavior Checklist (CBCL), and Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), depending on age. Results Our cohort comprised 35 GBS-exposed and 65 matched non iGBS children, aged 1–14 years. The iGBS-exposed group had 17 (48.6%) children with impairment in ≥1 domain compared to 25 (38%) in the non iGBS group (unadjusted OR, 1.51; 95% CI, .65–3.46), 9 (26%) children with “multi-domain impairment” compared to 10 (15.4%) in the non iGBS group (unadjusted OR, 1.90; 95% CI, .69–5.24), and 1 (2.9%) child with moderate to severe impairment compared to 3 (4.6%) in the non iGBS group (unadjusted OR, .60; 95% CI, .06–6.07). In the iGBS group, more children had motor impairments compared with the non iGBS group (unadjusted OR, 10.7; 95% CI, 1.19–95.69; P = .034). Conclusions Children with iGBS seem at higher risk of developing motor impairments compared with a non iGBS group.</description><subject>Adolescent</subject><subject>Child</subject><subject>Child Development</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Humans</subject><subject>Infant</subject><subject>Streptococcus agalactiae</subject><subject>Supplement</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhi0EoqWwYo-8QkgoYMeXOCyQhimUSoUuCmvLsU9IUBIHX0ZqV7wGr8eTYDRDBRsWli3783d8_CP0mJIXlLTspR1dGaZr2voOOqaCNZUULb1b1kSoiiumjtCDGL8SQqki4j46YlwIJYk4RjdXPqcBny9uNAveDuPkAiw_v_-I-CPk4B3sYPLrDEsyE77MyfoZIt70CQI-Cz6v-A2-SgHW5K23Nsfi2pk47gCfjhFMhFd4gz-YZAdw1dYPPqRyIbvrh-heb6YIjw7zCfr87u2n7fvq4vLsfLu5qCyndaq4bEVvS3tdbxUXyrU15Uw61rGO2q7lrOwb3gjZSysdNNwq0tWUENE3LeHsBL3ee9fczeBsaSWYSa9hnE241t6M-t-TZRz0F7_TqilSLorg2UEQ_LcMMel5jBamySzgc9S1aKQUilJW0Od71AYfY4D-tgwl-ndauqSlD2kV-snfL7tl_8RTgKd7oPzzf02_ACCYoek</recordid><startdate>20220120</startdate><enddate>20220120</enddate><creator>John, Hima B</creator><creator>Arumugam, Asha</creator><creator>Priya, Mohana</creator><creator>Murugesan, Nandhini</creator><creator>Rajendraprasad, Nandhini</creator><creator>Rebekah, Grace</creator><creator>Paul, Proma</creator><creator>Chandna, Jaya</creator><creator>Lawn, Joy E</creator><creator>Santhanam, Sridhar</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220120</creationdate><title>South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study</title><author>John, Hima B ; Arumugam, Asha ; Priya, Mohana ; Murugesan, Nandhini ; Rajendraprasad, Nandhini ; Rebekah, Grace ; Paul, Proma ; Chandna, Jaya ; Lawn, Joy E ; Santhanam, Sridhar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-4695fcab7bfc8458d921436d3b3b1cb943fc8a4756f6c6de74c80b21005f79043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Child Development</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Humans</topic><topic>Infant</topic><topic>Streptococcus agalactiae</topic><topic>Supplement</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>John, Hima B</creatorcontrib><creatorcontrib>Arumugam, Asha</creatorcontrib><creatorcontrib>Priya, Mohana</creatorcontrib><creatorcontrib>Murugesan, Nandhini</creatorcontrib><creatorcontrib>Rajendraprasad, Nandhini</creatorcontrib><creatorcontrib>Rebekah, Grace</creatorcontrib><creatorcontrib>Paul, Proma</creatorcontrib><creatorcontrib>Chandna, Jaya</creatorcontrib><creatorcontrib>Lawn, Joy E</creatorcontrib><creatorcontrib>Santhanam, Sridhar</creatorcontrib><collection>Open Access: Oxford University Press Open Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>John, Hima B</au><au>Arumugam, Asha</au><au>Priya, Mohana</au><au>Murugesan, Nandhini</au><au>Rajendraprasad, Nandhini</au><au>Rebekah, Grace</au><au>Paul, Proma</au><au>Chandna, Jaya</au><au>Lawn, Joy E</au><au>Santhanam, Sridhar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2022-01-20</date><risdate>2022</risdate><volume>74</volume><issue>Supplement_1</issue><spage>S24</spage><epage>S34</epage><pages>S24-S34</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Abstract Background This study is part of a multicountry matched-cohort study designed to estimate the risk of long-term neurodevelopmental impairment (NDI) of children exposed to invasive group B Streptococcus (iGBS). The specific objective of this paper is to compare NDI across domains of iGBS survivors with a matched non iGBS group in our population. Methods Survivors of iGBS in a South Indian hospital were identified and recruited between January 2020 and April 2021. Cases were compared with age- and gender-matched non iGBS children. Participants were assessed using Bayley Scales of Infant and Toddler Development–3rd edition (BSID-III), Wechsler Preschool and Primary Scale of Intelligence–4th edition (WPPSI-IV), Wechsler Intelligence Scale for Children–5th edition (WISC-V), Child Behavior Checklist (CBCL), and Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), depending on age. Results Our cohort comprised 35 GBS-exposed and 65 matched non iGBS children, aged 1–14 years. The iGBS-exposed group had 17 (48.6%) children with impairment in ≥1 domain compared to 25 (38%) in the non iGBS group (unadjusted OR, 1.51; 95% CI, .65–3.46), 9 (26%) children with “multi-domain impairment” compared to 10 (15.4%) in the non iGBS group (unadjusted OR, 1.90; 95% CI, .69–5.24), and 1 (2.9%) child with moderate to severe impairment compared to 3 (4.6%) in the non iGBS group (unadjusted OR, .60; 95% CI, .06–6.07). In the iGBS group, more children had motor impairments compared with the non iGBS group (unadjusted OR, 10.7; 95% CI, 1.19–95.69; P = .034). Conclusions Children with iGBS seem at higher risk of developing motor impairments compared with a non iGBS group.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>34558605</pmid><doi>10.1093/cid/ciab792</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2022-01, Vol.74 (Supplement_1), p.S24-S34
issn 1058-4838
1537-6591
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8775645
source MEDLINE; Oxford Journals A-Z Collection; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Adolescent
Child
Child Development
Child, Preschool
Cohort Studies
Humans
Infant
Streptococcus agalactiae
Supplement
title South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T20%3A12%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=South%20Indian%20Children%E2%80%99s%20Neurodevelopmental%20Outcomes%20After%20Group%20B%20Streptococcus%20Invasive%20Disease:%20A%20Matched-Cohort%20Study&rft.jtitle=Clinical%20infectious%20diseases&rft.au=John,%20Hima%20B&rft.date=2022-01-20&rft.volume=74&rft.issue=Supplement_1&rft.spage=S24&rft.epage=S34&rft.pages=S24-S34&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciab792&rft_dat=%3Cproquest_pubme%3E2576658113%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2576658113&rft_id=info:pmid/34558605&rft_oup_id=10.1093/cid/ciab792&rfr_iscdi=true